Eurofins CDMO Alphora Inc. Receives Investment from Government of Canada

The Government of Canada recently announced a contribution of $22.4 million through the Strategic Innovation Fund (SIF) to support a $64.1 million project by Eurofins CDMO Alphora Inc. This investment will support the construction of a new biologics facility, increasing domestic production capacity for antibodies and protein-based therapeutics that will allow Canadians to better respond to future pandemics. The facility will also enable Eurofins CDMO Alphora Inc. to accelerate clinical testing and the speed at which novel therapeutics are brought to market.

Eurofins CDMO Alphora Inc. is an OBIO® member.